EBSEmergent BioSolutions Inc.

EBS Stock Price, Valuation & Chart | Emergent BioSolutions Inc.

$6.460+0.24 (+3.86%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic EBS intrinsic value EBS calculated fair value vs price

Overview Financials Dividends Ratios

EBS Historical price chart

EBS Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization333.31M

PE Ratio4.49

EPS1.44

Trading Volume1.03M

Today's High/Low6.5/6.23

Dividend Yield0.00

52 Week High/Low14.06/4.36

Shares Outstanding51.60M

EBS Financial Statement

EBS Analyst ratings

EBS Analysis & performance metrics

EBS Company profile

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally…

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and…

EBS Management team

Name

Position

Richard S. Lindahl M.B.A.CFO

Executive Vice President, Chief Financial Officer & Treasurer

Jessica Perl

Senior Vice President, Corporate Secretary & General Counsel

Simon C. Lowry M.D.

Chief Medical Officer and Head of Research & Development

Joseph C. Papa Jr., M.B.A., R.Ph.CEO

Chief Executive Officer, President & Director

Paul A. Williams

Senior Vice President of Products Business

William Hartzel

Senior Vice President of Manufacturing & Bioservices

Michelle Pepin

Senior Vice President & Chief Human Resource Officer

Coleen Glessner

Executive Vice President of Quality, Ethics & Compliance

Name

Position

Richard S. Lindahl M.B.A.CFO

Executive Vice President, Chief Financial Officer & Treasurer

Jessica Perl

Senior Vice President, Corporate Secretary & General Counsel

Simon C. Lowry M.D.

Chief Medical Officer and Head of Research & Development

Joseph C. Papa Jr., M.B.A., R.Ph.CEO

Chief Executive Officer, President & Director

Paul A. Williams

Senior Vice President of Products Business

William Hartzel

Senior Vice President of Manufacturing & Bioservices

Michelle Pepin

Senior Vice President & Chief Human Resource Officer

Coleen Glessner

Executive Vice President of Quality, Ethics & Compliance

Management Team

Richard S. Lindahl M.B.A.CFO

Executive Vice President, Chief Financial Officer & Treasurer

Jessica Perl

Senior Vice President, Corporate Secretary & General Counsel

Simon C. Lowry M.D.

Chief Medical Officer and Head of Research & Development

Joseph C. Papa Jr., M.B.A., R.Ph.CEO

Chief Executive Officer, President & Director

Paul A. Williams

Senior Vice President of Products Business

William Hartzel

Senior Vice President of Manufacturing & Bioservices

Michelle Pepin

Senior Vice President & Chief Human Resource Officer

Coleen Glessner

Executive Vice President of Quality, Ethics & Compliance

Management

Richard S. Lindahl M.B.A.CFO

Executive Vice President, Chief Financial Officer & Treasurer

Jessica Perl

Senior Vice President, Corporate Secretary & General Counsel

Simon C. Lowry M.D.

Chief Medical Officer and Head of Research & Development

Joseph C. Papa Jr., M.B.A., R.Ph.CEO

Chief Executive Officer, President & Director

Paul A. Williams

Senior Vice President of Products Business

William Hartzel

Senior Vice President of Manufacturing & Bioservices

Michelle Pepin

Senior Vice President & Chief Human Resource Officer

Coleen Glessner

Executive Vice President of Quality, Ethics & Compliance

Total 8 executives

EBS Frequently asked questions

What is Emergent BioSolutions Inc. (EBS) Stock Price?

Current stock price of Emergent BioSolutions Inc. (EBS) stock is $6.460. The stock price is +3.86% higher in the session. The intraday range can be seen from this page. Volume of Emergent BioSolutions Inc. (EBS) stock is 1.03M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Emergent BioSolutions Inc. (EBS) stock price going up or down today?

The stock price of Emergent BioSolutions Inc. (EBS) can change with earnings, company news, and overall market sentiment. Emergent BioSolutions Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Emergent BioSolutions Inc. stock expensive at its current price?

Whether Emergent BioSolutions Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for EBS on this page is 4.49. EPS on this page is 1.44. Compare those figures with peers and growth expectations before deciding if the current Emergent BioSolutions Inc. price is justified.

How has the stock price of Emergent BioSolutions Inc. (EBS) performed historically?

Historical performance for Emergent BioSolutions Inc. (EBS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how EBS reacted to past earnings and market events.

Should I buy Emergent BioSolutions Inc. (EBS) stock, at this price?

Buying Emergent BioSolutions Inc. (EBS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.